<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01148147</url>
  </required_header>
  <id_info>
    <org_study_id>CE 93/09</org_study_id>
    <secondary_id>2009-013681-92</secondary_id>
    <nct_id>NCT01148147</nct_id>
  </id_info>
  <brief_title>Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty</brief_title>
  <acronym>PREVENT-ICARUS</acronym>
  <official_title>Prevention of Cardiac and Vascular Periprocedural Complications in Patients Undergoing Coronary Angiography or Angioplasty: Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty. A Prospective Double-blind Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero Universitaria Maggiore della Carita</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero Universitaria Maggiore della Carita</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to evaluate the benefits from adjunctive intracoronary administration of
      adenosin in elective patients undergoing coronary angioplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will investigate the effects of adjunctive intracoronary administration of
      adenosine on periprocedural myocardial infarction as compared to placebo.

      This is a double-blind randomized trial single-center study. The enrollment will last 10
      months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in troponin I (&gt; 3 times the upper normal limit)</measure>
    <time_frame>At 12 hours after the procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE(death, MI, urgent target-vessel revascularization)</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic Coronary flow, as evaluated by corrected TIMI frame count.</measure>
    <time_frame>1 minute after the final stent implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Coronary Angioplasty</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intracoronary Placebo administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adenosine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intracoronary adenosine administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adenosine</intervention_name>
    <description>Intracoronary adenosine administration (180 ug for LCA and 120 ug for RCA)</description>
    <arm_group_label>Adenosine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Intracoronary Placebo administration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing elective coronary angioplasty

        Exclusion Criteria:

        Marked Bradycardia (&lt; 40 bpm)

          -  Previous allergy to adenosine

          -  Inability to sign the informed consent

          -  Asthma

          -  Elevated cardiac enzymes (troponin I o CK-MB)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe De Luca, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOU Maggiore della Carit√†</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Giuseppe De Luca</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2010</study_first_submitted>
  <study_first_submitted_qc>June 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2010</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Giuseppe De Luca, MD, PhD</name_title>
    <organization>AOU Maggiore della Carita - Eastern Piedmont University</organization>
  </responsible_party>
  <keyword>Adenosine</keyword>
  <keyword>randomized trial</keyword>
  <keyword>periprocedural myocardial necrosis</keyword>
  <keyword>elective coronary angioplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

